HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ginna G Laport Selected Research

Cell Transplantation

1/2018Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703).
3/2017CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
1/2016Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network.
12/2015Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
10/2015Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
9/2015Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
6/2015Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.
6/2014Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasms.
2/2014Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.
12/2013Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ginna G Laport Research Topics

Disease

11Graft vs Host Disease (Graft-Versus-Host Disease)
07/2017 - 03/2005
9Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2015 - 09/2003
8Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2016 - 01/2006
6Hematologic Neoplasms (Hematological Malignancy)
03/2017 - 01/2003
5Neoplasms (Cancer)
01/2020 - 07/2009
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 01/2008
5Hodgkin Disease (Hodgkin's Disease)
01/2018 - 10/2008
4Lymphoma (Lymphomas)
09/2015 - 01/2008
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2015 - 11/2012
3Leukemia
01/2015 - 01/2003
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2010 - 01/2008
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2014 - 02/2008
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
06/2014 - 02/2008
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2011 - 08/2008
2Philadelphia Chromosome
08/2011 - 08/2008
1Aplastic Anemia (Anemia, Hypoplastic)
03/2017
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2012
1Residual Neoplasm
08/2011
1Pathologic Complete Response
07/2011
1Myeloproliferative Disorders (Myeloproliferative Disorder)
02/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2008
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2004
1Lymphocytosis
09/2003

Drug/Important Bio-Agent (IBA)

5Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
07/2017 - 09/2005
4fludarabineIBA
01/2016 - 02/2008
4Rituximab (Mabthera)FDA Link
01/2016 - 07/2011
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2016 - 07/2006
3Etoposide (VP 16)FDA LinkGeneric
08/2008 - 05/2004
2Methotrexate (Mexate)FDA LinkGeneric
01/2016 - 07/2011
2Tacrolimus (Prograf)FDA LinkGeneric
01/2016 - 07/2011
2Carmustine (FIVB)FDA Link
08/2010 - 07/2006
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2009 - 09/2005
2HLA Antigens (Human Leukocyte Antigens)IBA
07/2009 - 03/2005
1VaccinesIBA
01/2020
1trans-crotonin (CTN)IBA
01/2018
1Daclizumab (Zenapax)FDA Link
03/2017
1Glucose (Dextrose)FDA LinkGeneric
09/2015
1Busulfan (Busulfex)FDA Link
12/2013
1Immunoconjugates (Immunoconjugate)IBA
01/2012
1Imatinib Mesylate (Gleevec)FDA Link
08/2011
1Vinorelbine (Navelbine)FDA LinkGeneric
08/2010
1GemcitabineFDA Link
08/2010
1Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2006
1MethylprednisoloneFDA LinkGeneric
07/2006
1CytokinesIBA
09/2003

Therapy/Procedure

32Cell Transplantation
01/2018 - 09/2003
10Transplantation
03/2017 - 07/2009
6Homologous Transplantation
12/2015 - 03/2005
6Drug Therapy (Chemotherapy)
09/2015 - 01/2003
6Therapeutics
07/2015 - 01/2006
5Lymphatic Irradiation
07/2017 - 09/2005
2Autologous Transplantation
12/2013 - 07/2009
2Radiotherapy
01/2012 - 01/2003
2Stem Cell Transplantation
01/2012 - 01/2003
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2017
1Aftercare (After-Treatment)
10/2015
1Hematopoietic Stem Cell Transplantation
02/2014
1Combination Drug Therapy (Combination Chemotherapy)
01/2012
1Salvage Therapy
07/2011